HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells
about
GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human diseaseSalinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell linesRegulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.HSPA5/Dna K may be a useful target for human disease therapies.Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.Regulation of dimethyl-fumarate toxicity by proteasome inhibitorsEmerging targets for glioblastoma stem cell therapyOSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer TherapiesGRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases.Low-dose salinomycin induces anti-leukemic responses in AML and MLL.Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death.Potassium as a pluripotency-associated element identified through inorganic element profiling in human pluripotent stem cells.Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and PromisesIdentification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.Phase I/II Trial of Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma: Final Results of Alliance N0874/ABTC 02.Salinomycin Hydroxamic Acids: Synthesis, Structure, and Biological Activity of Polyether Ionophore Hybrids.Translational gap in ongoing clinical trials for glioma.The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
P2860
Q28254667-75D323DC-597C-4B3C-BDE3-2AEE94B9DB3CQ28537942-A593D660-4EBB-4D57-BD72-105EF974D4BCQ34289307-31BF9DD8-AD39-4B6D-AF25-9447C8352B5BQ35110761-090596E9-6BD2-4E66-B0B7-DF4A2710E988Q36104984-5B2422D8-D1C6-4DC1-88F8-61DDCA6A8EB9Q36215658-5E66B476-F5C6-42E3-97BD-1B4E16427CA6Q36502009-34C99986-04C0-45EA-B556-FDDBBEA51D5CQ36808317-9F6F8F71-BAD3-441C-8427-AADF533F5794Q36830763-702C4792-82D4-43BD-8C36-066DAD5422B4Q37687407-FFB23315-B7B9-40BE-A2D9-0ADEA3A364E2Q38731925-67064281-B18E-4CA9-AF4D-EDFCFD374371Q38882381-8BB0723B-7CC3-4E37-A31D-E1D508B3902BQ40974003-3DB4C3B2-7B6E-4F2D-B2FC-07D90E022DC4Q41664067-22E38FEC-98E0-41CE-ADDF-C25BA1D2A86EQ42316990-A22DADB1-566C-44CA-8DF2-9F91607AC966Q42696115-DBE4A528-9E66-4A70-AD00-49C39A991500Q42732849-38F8AA45-A92A-4CA2-B6E8-A18BD5BAD3B0Q48002716-71C343C1-4F50-423B-A045-A038695413FDQ51746838-54E67A5C-1183-4B2B-AA43-D8A835ED967C
P2860
HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HDAC inhibitors enhance the le ...... rental and stem-like GBM cells
@en
HDAC inhibitors enhance the le ...... ental and stem-like GBM cells.
@nl
type
label
HDAC inhibitors enhance the le ...... rental and stem-like GBM cells
@en
HDAC inhibitors enhance the le ...... ental and stem-like GBM cells.
@nl
prefLabel
HDAC inhibitors enhance the le ...... rental and stem-like GBM cells
@en
HDAC inhibitors enhance the le ...... ental and stem-like GBM cells.
@nl
P2093
P2860
P356
P1476
HDAC inhibitors enhance the le ...... rental and stem-like GBM cells
@en
P2093
Adam Conley
Andrew Poklepovic
Jane L Roberts
Laurence Booth
Nichola Cruickshanks
Steven Grant
Thomas Ridder
P2860
P304
P356
10.4161/CBT.27309
P50
P577
2013-12-18T00:00:00Z